{"id":"W2911213912","doi":"10.6004/jnccn.2018.7066","title":"Real-World Outcomes of Adjuvant Chemotherapy for Node-Negative and Node-Positive HER2-Positive Breast Cancer","year":2019,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Cancer Foundation; Alberta Health Services; Baker Hughes (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Trastuzumab; Epirubicin; Docetaxel; Breast cancer; Internal medicine; Oncology; Carboplatin; Cyclophosphamide; Chemotherapy; Cancer; Gynecology; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009824291,0.0002283134,0.0004768006,0.00005067968,0.0001208287,0.0000131036,0.0002015114,0.00007222297,0.00002766222],"category_scores_gemma":[0.00002236443,0.0001561158,0.0002593168,0.0001634241,0.0001660397,0.00001498238,0.00009993404,0.0001339085,4.329598e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002105962,"about_ca_system_score_gemma":0.0002580604,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002123714,"about_ca_topic_score_gemma":0.0001562456,"domain_scores_codex":[0.9987569,0.00008252882,0.0003677584,0.0002322661,0.000349562,0.0002109675],"domain_scores_gemma":[0.9967239,0.0002755293,0.000712269,0.0001136319,0.002120343,0.00005433321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007411169,0.0003212254,0.8661284,0.0001342635,0.008818616,0.000001991674,0.000954556,0.04442186,0.02812279,0.0007455249,0.03815296,0.004786672],"study_design_scores_gemma":[0.002963862,0.0001401534,0.9839532,0.0003113276,0.0001688682,0.0000219041,0.0001090028,0.0001114077,0.009671602,0.0006050704,0.001755682,0.0001878625],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9759293,0.006793117,0.000142537,0.01225292,0.001496032,0.0009179146,0.00185025,0.000005421316,0.0006125083],"genre_scores_gemma":[0.9928564,0.001950979,0.0008203783,0.002975581,0.0009798115,0.00004479151,0.00001374856,0.00003072412,0.0003275635],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1178249,"threshold_uncertainty_score":0.6366218,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01437594280338184,"score_gpt":0.305227594715918,"score_spread":0.2908516519125362,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}